Editorial: Inhibitors of CDK family: New perspective and rationale for drug combination in preclinical models of solid tumors

Bibliographic Details
Main Authors: Andrea Cavazzoni, Arianna Palladini
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-03-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1180650/full
_version_ 1797858985689219072
author Andrea Cavazzoni
Arianna Palladini
author_facet Andrea Cavazzoni
Arianna Palladini
author_sort Andrea Cavazzoni
collection DOAJ
first_indexed 2024-04-09T21:22:14Z
format Article
id doaj.art-f69b31a7bd3f4d53a415b604584780d5
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-04-09T21:22:14Z
publishDate 2023-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-f69b31a7bd3f4d53a415b604584780d52023-03-28T05:41:52ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2023-03-011310.3389/fonc.2023.11806501180650Editorial: Inhibitors of CDK family: New perspective and rationale for drug combination in preclinical models of solid tumorsAndrea Cavazzoni0Arianna Palladini1Department of Medicine and Surgery, University of Parma, Parma, ItalyDepartment of Molecular Medicine, University of Pavia, Pavia, Italyhttps://www.frontiersin.org/articles/10.3389/fonc.2023.1180650/fullCDKsolid tumorspre-clinicalcombinationRb
spellingShingle Andrea Cavazzoni
Arianna Palladini
Editorial: Inhibitors of CDK family: New perspective and rationale for drug combination in preclinical models of solid tumors
Frontiers in Oncology
CDK
solid tumors
pre-clinical
combination
Rb
title Editorial: Inhibitors of CDK family: New perspective and rationale for drug combination in preclinical models of solid tumors
title_full Editorial: Inhibitors of CDK family: New perspective and rationale for drug combination in preclinical models of solid tumors
title_fullStr Editorial: Inhibitors of CDK family: New perspective and rationale for drug combination in preclinical models of solid tumors
title_full_unstemmed Editorial: Inhibitors of CDK family: New perspective and rationale for drug combination in preclinical models of solid tumors
title_short Editorial: Inhibitors of CDK family: New perspective and rationale for drug combination in preclinical models of solid tumors
title_sort editorial inhibitors of cdk family new perspective and rationale for drug combination in preclinical models of solid tumors
topic CDK
solid tumors
pre-clinical
combination
Rb
url https://www.frontiersin.org/articles/10.3389/fonc.2023.1180650/full
work_keys_str_mv AT andreacavazzoni editorialinhibitorsofcdkfamilynewperspectiveandrationalefordrugcombinationinpreclinicalmodelsofsolidtumors
AT ariannapalladini editorialinhibitorsofcdkfamilynewperspectiveandrationalefordrugcombinationinpreclinicalmodelsofsolidtumors